Tech Company Financing Transactions
NanoView Biosciences Funding Round
On 10/11/2018, NanoView Biosciences raised $10 million in Series B funding from Northpond Ventures, PBM Capital and Sands Capital Management.
Transaction Overview
Company Name
Announced On
10/11/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds will be used to complete development of the ExoView system, NanoView's complete exosome detection and characterization platform, and to prepare the product for commercial launch.
Company Information
Company Status
Private & Independent
Industry
Nanotechnology
Mailing Address
1380 Soldiers Field Rd. 100
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Website
Email Address
Overview
NanoView, a Boston-based, privately-held company, enables life science researchers to better understand the biological role of exosomes and their potential use as biomarkers for improving the diagnosis, prognosis, treatment, and monitoring of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jerry Williamson
Chief Operating Officer
David Freedman
VP - Sales
Andrew Malloy
Browse more venture capital transactions:
Prev: 10/11/2018: Lumenari venture capital transaction
Next: 10/11/2018: My Ally venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs